Filing Signals

Source: SEC EDGAR Compiled 2026-11-13 17:17 UTC 23 automated checks passing

← All events

SOLESENCE, INC.

CIK 883107 SLSN·Cosmetics And Toiletries · All EDGAR filings ↗

Progression

  1. Late filing NT 10-Q
  2. Restatement 8-K +7d
  3. Material weakness 10-Q/A +81d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

Material weakness high Filing comparison

SOLESENCE, INC. reported a material weakness in internal control

Internal control reported effective → Material weakness in internal control

Based on that reevaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level as of June 30, 2026 because of the material weakness in internal control over financial reporting described below. A material weakness exists when one or more deficiencies in internal control over financial reporting create a reasonable possibility that a material misstatement of annual or interim financial statements will not…
Evidence
Current state
material_weakness
Current state label
Material weakness in internal control
Direction
newly reported
Prior filed
2026-11-10
Prior form
10-Q/A
Prior state
effective
Prior state label
Internal control reported effective
Remediation stated
No
Severity
high
Source
Item 9A internal control conclusion, compared with the prior filing
Why
The company's conclusion on internal control over financial reporting changed: a material weakness was newly reported, or a previously reported one no longer appears.

Source filing ↗ Prior filing ↗

Material weakness Filing comparison

SOLESENCE, INC. reported internal control effective again after a material weakness

Material weakness in internal control → Internal control reported effective

The weakness was first reported on 2026-08-19 — 83 days and 1 annual report before this one.

Based on this reassessment and the COSO criteria, management, including our Chief Executive Officer and Chief Financial Officer, concluded that the Company’s internal control over financial reporting was not effective as of December 31, 2024 because of the material weaknesses described above. This conclusion supersedes management’s conclusion in the originally filed Form 10-Q that internal control over financial reporting was effective as of September 30, 2025. 25 Inventory Costing Remediation Activities…
Evidence
Current state
effective
Current state label
Internal control reported effective
Direction
remediated
Prior filed
2026-08-19
Prior form
10-Q
Prior state
material_weakness
Prior state label
Material weakness in internal control
Remediation stated
No
Severity
normal
Source
Item 9A internal control conclusion, compared with the prior filing
Weakness annual reports
1
Weakness days reported
83
Weakness first reported
2026-08-19
Why
The company's conclusion on internal control over financial reporting changed: a material weakness was newly reported, or a previously reported one no longer appears.

Source filing ↗ Prior filing ↗

Material weakness Filing comparison

SOLESENCE, INC. reported internal control effective again after a material weakness

Material weakness in internal control → Internal control reported effective

Based on this reassessment and the COSO criteria, management, including our Chief Executive Officer and Chief Financial Officer, concluded that the Company’s internal control over financial reporting was not effective as of December 31, 2025 because of the material weaknesses described above. This conclusion supersedes management’s conclusion in the originally filed Form 10-Q that internal control over financial reporting was effective as of March 31, 2026. Inventory Costing Remediation Activities Subsequent to…
Evidence
Current state
effective
Current state label
Internal control reported effective
Direction
remediated
Prior filed
2026-08-19
Prior form
10-Q
Prior state
material_weakness
Prior state label
Material weakness in internal control
Remediation stated
No
Severity
normal
Source
Item 9A internal control conclusion, compared with the prior filing
Why
The company's conclusion on internal control over financial reporting changed: a material weakness was newly reported, or a previously reported one no longer appears.

Source filing ↗ Prior filing ↗

Material weakness Filing comparison

SOLESENCE, INC. reported internal control effective again after a material weakness

Material weakness in internal control → Internal control reported effective

Based on this reassessment and the COSO criteria, management, including our Chief Executive Officer and Chief Financial Officer, concluded that the Company’s internal control over financial reporting was not effective as of December 31, 2025 because of the material weaknesses described above. This conclusion supersedes management’s conclusion in the originally filed Form 10-Q that internal control over financial reporting was effective as of June 30, 2026. Inventory Costing Remediation Activities Subsequent to…
Evidence
Current state
effective
Current state label
Internal control reported effective
Direction
remediated
Prior filed
2026-08-19
Prior form
10-Q
Prior state
material_weakness
Prior state label
Material weakness in internal control
Remediation stated
No
Severity
normal
Source
Item 9A internal control conclusion, compared with the prior filing
Why
The company's conclusion on internal control over financial reporting changed: a material weakness was newly reported, or a previously reported one no longer appears.

Source filing ↗ Prior filing ↗

Restatement SEC item code

SOLESENCE, INC. said previously issued financial statements should no longer be relied upon

Item 4.02(a) — management or the board reached the conclusion

Evidence
Item code
4.02
Item title
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Limb
a
Limb basis
filing says management or the board concluded
Limb label
Item 4.02(a) — management or the board reached the conclusion
Severity
normal
Source
SEC 8-K item code
Why
The company told investors that previously issued financial statements should no longer be relied upon.

Source filing ↗

Late filing elevated Filing comparison

SOLESENCE, INC. filed its quarterly report late and said it expects a significant change in results

expects significant change in results Filed on the statutory due date.

The registrant recently discovered that it had applied an improper inventory costing methodology, and the registrant is in the process of determining appropriate corrective measures. Cautionary Notice Regarding Forward-Looking Statements This Form 12b-25 includes information that constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the Company’s current beliefs, assumptions and expectations regarding future events, which in turn are based on information currently available to the Company. Such forward-looking statements include statements regarding the anticipated timing of filing the…
Evidence
Anticipates significant change
Yes
Days past due date
0
Other periodic reports filed
Yes
Routine
No
Severity
elevated
Source
Form 12b-25 (notification of late filing)
Stated reason
The registrant recently discovered that it had applied an improper inventory costing methodology, and the registrant is in the process of determining appropriate corrective measures. Cautionary Notice Regarding Forward-Looking Statements This Form 12b-25 includes information that constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the Company’s current beliefs, assumptions and expectations regarding future events, which in turn are based on information currently available to the Company. Such forward-looking statements include statements regarding the anticipated timing of filing the…
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗